Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2017 Filed Jan 21, 2017 00:58 UTC |
Sorgenti HaroldDirector
|
GrantOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001593968-17-000128 · primary_01.xml · derivative · entry 1 Sorgenti Harold · CIK 0001420115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock and Series B Preferred · 40,000 shares Expires 2027-01-19 F1 · derivative.exercise_date: 100% vest Immediately Read SEC document |
| January 19, 2017 Filed Jan 21, 2017 00:54 UTC |
FOSTER ANDREW BExecutive Vice President
|
GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001593968-17-000126 · primary_01.xml · derivative · entry 1 FOSTER ANDREW B · CIK 0001285221 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock and Series B Preferred · 100,000 shares Expires 2027-01-19 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| January 19, 2017 Filed Jan 21, 2017 00:57 UTC |
Waltz ToddExecutive Vice President, CFO
|
GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001593968-17-000127 · primary_01.xml · derivative · entry 1 Waltz Todd · CIK 0001383895 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock and Series B Preferred · 100,000 shares Expires 2027-01-19 F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant. Read SEC document |
| January 19, 2017 Filed Jan 21, 2017 00:53 UTC |
BARTON FRANCIS PDirector
|
GrantOption (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001593968-17-000125 · primary_01.xml · derivative · entry 1 BARTON FRANCIS P · CIK 0001236181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock and Series B Preferred · 50,000 shares Expires 2027-01-19 F1 · derivative.exercise_date: 100% vest Immediately Read SEC document |
| November 17, 2016 Filed Nov 22, 2016 19:25 UTC |
Beebe Lydia IDirector
|
GrantOption (right to buy) · Derivative | 10,000 | $1.85 Strike: $1.85 | $18,500.00 |
DisclosureSEC source: 0000738214-16-000006 · primary_doc.xml · derivative · entry 2 Beebe Lydia I · CIK 0001635208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common stock and Series B · 10,000 shares Expires 2026-11-17 F1 · derivative.exercise_date: 50% vest over two years. Read SEC document |
| November 17, 2016 Filed Nov 22, 2016 19:25 UTC |
Beebe Lydia IDirector
|
GrantOption (right to buy) | 10,000 | $1.85 | $18,500.00 |
DisclosureSEC source: 0000738214-16-000006 · primary_doc.xml · nonDerivative · entry 1 Beebe Lydia I · CIK 0001635208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.